Answers are grounded in this paper and cite their sources.
Developers of digital therapeutics have the duty to create products that are safe, ethical and effective, without waiting for government regulation. Further, by self-regulating, following principles such as those provided by the Digital Therapeutics Alliance, they can develop products that serve patients better, while continuing to innovate.
No takes yet. Share an insight, caveat, or question.
Rassi-Cruz et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: